This Article Full Text Full Text (PDF) All Versions of this Article: 110/13/1794    most recent 01.CIR.0000143073.60937.50v1 Alert me when this article is cited Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Request Permissions Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Chong, A. Y. Articles by Lip, G. Y.H. Search for Related Content PubMed PubMed Citation Articles by Chong, A. Y. Articles by Lip, G. Y.H. Related Collections Congestive Endothelium/vascular type/nitric oxide Other Vascular biology

(Circulation. 2004;110:1794-1798.)
© 2004 American Heart Association, Inc.

Heart Failure

Endothelial Dysfunction and Damage in Congestive Heart Failure

Relation of Flow-Mediated Dilation to Circulating Endothelial Cells, Plasma Indexes of Endothelial Damage, and Brain Natriuretic Peptide

Aun Yeong Chong, MRCP; Andrew D. Blann, PhD; Jeetesh Patel, PhD; Bethan Freestone, MRCP; Elizabeth Hughes, MD; Gregory Y.H. Lip, MD

From the Haemostasis Thrombosis and Vascular Biology Unit, University Department of Medicine, City Hospital, Birmingham, England, UK.

Correspondence to Prof G.Y.H. Lip, Haemostasis Thrombosis and Vascular Biology Unit, University Department of Medicine, City Hospital, Birmingham B18 7QH, England, UK. E-mail g.y.h.lip{at}bham.ac.uk

Received December 30, 2003; de novo received April 10, 2004; accepted June 18, 2004.

Background— Congestive heart failure (CHF) is associated with endothelial perturbation (as defined by flow-mediated endothelial-dependent vasodilation [FMD, an index of endothelial dysfunction], circulating endothelial cells [CECs, an index of endothelial damage], or plasma indexes of endothelial damage/dysfunction [eg, von Willebrand factor (vWf) and soluble thrombomodulin (sTM)]) and raised plasma levels of brain natriuretic peptide (BNP, a peptide hormone associated with left ventricular systolic dysfunction and prognosis). However, the relations between these parameters are unclear.

Methods and Results— To test the hypothesis that there is a relation between endothelial perturbation (defined by FMD, CECs, vWf, and sTM) and BNP in CHF, we studied these indexes in 30 patients with CHF who were compared with 20 age-matched control subjects. FMD, CECs, plasma vWf, and BNP levels (but not sTM) were all abnormal in patients with CHF. There were significant inverse correlations between FMD and vWf (P=0.001), CECs (P=0.002) and BNP (P=0.006) as well as a positive correlation between CECs and vWf (P=0.032). In multivariate analysis, BNP (P<0.001) and FMD (P<0.001) were both independently associated with CHF.

Conclusions— Ample evidence of endothelial cell damage/dysfunction in CHF cannot be fully explained by the variance in plasma BNP per se. Therefore, the routes by which these indexes influence the pathophysiology of CHF as well as predict adverse outcomes may be independent.

Key Words: heart failure • endothelium • von Willebrand factor • endothelium-derived factors • natriuretic peptides

This article has been cited by other articles:

				B. Freestone, F. Gustafsson, A. Y. Chong, P. Corell, C. Kistorp, P. Hildebrandt, and G. Y. H. Lip Influence of Atrial Fibrillation on Plasma Von Willebrand Factor, Soluble E-Selectin, and N-Terminal Pro B-type Natriuretic Peptide Levels in Systolic Heart Failure Chest, May 1, 2008; 133(5): 1203 - 1208. [Abstract] [Full Text] [PDF]

				C. Demiot, F. Dignat-George, J.-O. Fortrat, F. Sabatier, C. Gharib, I. Larina, G. Gauquelin-Koch, R. Hughson, and M.-A. Custaud WISE 2005: chronic bed rest impairs microcirculatory endothelium in women Am J Physiol Heart Circ Physiol, November 1, 2007; 293(5): H3159 - H3164. [Abstract] [Full Text] [PDF]

				A.-Y. Chong and G. Y.H. Lip Viewpoint: The prothrombotic state in heart failure: A maladaptive inflammatory response? Eur J Heart Fail, February 1, 2007; 9(2): 124 - 128. [Abstract] [Full Text] [PDF]

				C. J. Boos, G. Y.H. Lip, and A. D. Blann Circulating Endothelial Cells in Cardiovascular Disease J. Am. Coll. Cardiol., October 17, 2006; 48(8): 1538 - 1547. [Abstract] [Full Text] [PDF]

				S. Kathiresan, P. Gona, M. G. Larson, D. Levy, C. Newton-Cheh, T. J. Wang, E. J. Benjamin, R. S. Vasan, J. A. Vita, G. F. Mitchell, et al. Response to Letter Regarding Article, "Cross-Sectional Relations of Multiple Biomarkers From Distinct Biological Pathways to Brachial Artery Endothelial Function" Circulation, September 5, 2006; 114(10): e384 - e384. [Full Text] [PDF]

				C. A. Skrabal, Y. H. Choi, A. Kaminski, M. Steiner, G. Kundt, G. Steinhoff, and A. Liebold Circulating endothelial cells demonstrate an attenuation of endothelial damage by minimizing the extracorporeal circulation. J. Thorac. Cardiovasc. Surg., August 1, 2006; 132(2): 291 - 296. [Abstract] [Full Text] [PDF]

				P. van der Harst, A. A. Voors, W. H. van Gilst, M. Bohm, and D. J. van Veldhuisen Statins in the treatment of chronic heart failure: Biological and clinical considerations Cardiovasc Res, August 1, 2006; 71(3): 443 - 454. [Abstract] [Full Text] [PDF]

				E. Ingelsson, K. Bjorklund-Bodegard, L. Lind, J. Arnlov, and J. Sundstrom Diurnal blood pressure pattern and risk of congestive heart failure. JAMA, June 28, 2006; 295(24): 2859 - 2866. [Abstract] [Full Text] [PDF]

				R. P. Blankfield Can Natriuretic Peptide Levels Predict the Cardiovascular Complications of COX-2 Inhibitors and Nonsteroidal Anti-inflammatory Drugs? J Am Board Fam Med, March 1, 2006; 19(2): 178 - 182. [Abstract] [Full Text] [PDF]

				A. Y. Chong, G. Y.H. Lip, B. Freestone, and A. D. Blann Increased circulating endothelial cells in acute heart failure: Comparison with von Willebrand factor and soluble E-selectin Eur J Heart Fail, March 1, 2006; 8(2): 167 - 172. [Abstract] [Full Text] [PDF]

				O. O. Ogunshola, V. Djonov, R. Staudt, J. Vogel, and M. Gassmann Chronic excessive erythrocytosis induces endothelial activation and damage in mouse brain Am J Physiol Regulatory Integrative Comp Physiol, March 1, 2006; 290(3): R678 - R684. [Abstract] [Full Text] [PDF]

				S. Kathiresan, P. Gona, M. G. Larson, J. A. Vita, G. F. Mitchell, G. H. Tofler, D. Levy, C. Newton-Cheh, T. J. Wang, E. J. Benjamin, et al. Cross-Sectional Relations of Multiple Biomarkers From Distinct Biological Pathways to Brachial Artery Endothelial Function Circulation, February 21, 2006; 113(7): 938 - 945. [Abstract] [Full Text] [PDF]

				D. H. Kim, H.-B. Leu, J.-W. Chen, S.-J. Lin, H. C. Ott, D. A. Taylor, F. Bertolini, P. Mancuso, R. S. Kerbel, C. J. Boos, et al. Circulating Endothelial Progenitor Cells N. Engl. J. Med., December 15, 2005; 353(24): 2613 - 2616. [Full Text] [PDF]

				S. M. Kawut, E. M. Horn, K. K. Berekashvili, A. C. Widlitz, E. B. Rosenzweig, and R. J. Barst von Willebrand Factor Independently Predicts Long-term Survival in Patients With Pulmonary Arterial Hypertension Chest, October 1, 2005; 128(4): 2355 - 2362. [Abstract] [Full Text] [PDF]

				P. M. McKie and J. C. Burnett Jr B-Type Natriuretic Peptide as a Biomarker Beyond Heart Failure: Speculations and Opportunities Mayo Clin. Proc., August 1, 2005; 80(8): 1029 - 1036. [Abstract] [PDF]

				K. W. Lee, G. Y. H. Lip, M. Tayebjee, W. Foster, and A. D. Blann Circulating endothelial cells, von Willebrand factor, interleukin-6, and prognosis in patients with acute coronary syndromes Blood, January 15, 2005; 105(2): 526 - 532. [Abstract] [Full Text] [PDF]